Sabal Therapeutics
  • Partners
  • News
  • Careers
  • Contact
  • Company
  • Mission
  • Expertise
  • Solutions
    • Sales & Marketing Management
    • Product Distribution
    • Regulatory Compliance
    • Accounting & Back Office
  • Start a Conversation
  • Careers
  • Contact
Header image

 

NexiclonXR ICONAthena Bioscience Announces Launch of Nexiclon™ XR, the Only Once-Daily Clonidine Extended-Release Tablets for Treatment of Hypertension

March 3, 2022

 

 

Athena logoSabal Therapeutics Announces Sales and Marketing Agreement to Promote Athena Bioscience Cardiovascular Product Portfolio

February 22, 2022

CONTACT US   I   PRIVACY

©2021 Sabal Therapeutics, LLC. All rights reserved. Created in the USA. SAB-WEB-001-04 02/2021

Sabal Therapeutics